Celldex Therapeutics, Inc.
CLDX· Nasdaq
Released Aug 8, 2017, after the close
10-Q filed Aug 8, 2017, 39 days after period end · 0001104659-17-050250
| Metric | Q2 2017 | Q2 2016 | Q2 2015 | Q2 2014 |
|---|---|---|---|---|
| Revenue | $3.83M | $1.39M | $2.18M | $592.00K |
| EPS Diluted | -$3.42 | -$0.32 | -$0.33 | -$0.32 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Celldex Therapeutics, Inc. · CIK 744218 · Engraved from SEC EDGAR